IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
1-Year Return
45.66%
This Quarter Return
+5.14%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
-$23M
(-13%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-12.46%
Top 10 Holdings %
Top 10 Hldgs %
41.87%
Holding
82
New
17
Increased
14
Reduced
14
Closed
23
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.12M |
| 2 |
Sanofi
SNY
|
$3.59M |
| 3 |
Cigna
CI
|
$2.93M |
| 4 |
AbbVie
ABBV
|
$2.9M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$2.47M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.2M |
| 2 |
MDCO
Medicines Co
MDCO
|
$3.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$3.51M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.91M |
| 5 |
Merck
MRK
|
$2.88M |
Sector Composition
| 1 | Healthcare | 79.02% |
| 2 | Financials | 3.16% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Glaukos
GKOS
$5.39B
| $2.49M | 1.41% |
60,000
-40,000
| -40% | -$1.66M |
|
|
AVXS
27
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.47M | 1.39% |
+30,000
| New | +$2.47M |
|
|
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.34M | 1.32% |
250,000
| – | – |
|
|
TSRO
29
DELISTED
TESARO, Inc.
TSRO
| $2.1M | 1.19% |
+15,000
| New | +$2.1M |
|
30
Biogen
BIIB
$20.6B
| $2.04M | 1.15% |
7,500
-2,500
| -25% | -$678K |
|
|
XENT
31
DELISTED
Intersect ENT, Inc
XENT
| $1.96M | 1.11% |
70,000
-30,000
| -30% | -$839K |
|
32
Abbott
ABT
$231B
| $1.94M | 1.1% |
40,000
-30,000
| -43% | -$1.46M |
|
33
Sangamo Therapeutics
SGMO
$165M
| $1.89M | 1.07% |
215,000
+65,000
| +43% | +$572K |
|
34
Medtronic
MDT
$119B
| $1.78M | 1% |
+20,000
| New | +$1.78M |
|
35
AnaptysBio
ANAB
$613M
| $1.68M | 0.95% |
70,000
+20,000
| +40% | +$479K |
|
36
Boston Scientific
BSX
$159B
| $1.53M | 0.86% |
+55,000
| New | +$1.53M |
|
|
GWPH
37
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.5M | 0.85% |
+15,000
| New | +$1.5M |
|
|
OMED
38
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.33M | 0.75% |
400,000
-90,000
| -18% | -$300K |
|
|
AKAO
39
DELISTED
Achaogen, Inc.
AKAO
| $1.3M | 0.74% |
60,000
| – | – |
|
|
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
| $1.23M | 0.7% |
+85,000
| New | +$1.23M |
|
|
EPZM
41
DELISTED
Epizyme, Inc
EPZM
| $1.13M | 0.64% |
75,000
| – | – |
|
|
DPLO
42
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.11M | 0.63% |
75,000
| – | – |
|
43
Wave Life Sciences
WVE
$1.32B
| $1.02M | 0.58% |
+55,000
| New | +$1.02M |
|
44
CytomX Therapeutics
CTMX
$376M
| $930K | 0.53% |
60,000
-15,000
| -20% | -$233K |
|
45
Edwards Lifesciences
EW
$47.5B
| $887K | 0.5% |
+22,500
| New | +$887K |
|
46
Xencor
XNCR
$610M
| $844K | 0.48% |
+40,000
| New | +$844K |
|
|
CORI
47
DELISTED
Corium International, Inc.
CORI
| $746K | 0.42% |
+100,000
| New | +$746K |
|
|
CBAY
48
DELISTED
Cymabay Therapeutics
CBAY
| $605K | 0.34% |
+105,000
| New | +$605K |
|
49
ADMA Biologics
ADMA
$4.03B
| $555K | 0.31% |
150,000
+50,000
| +50% | +$185K |
|
|
RXDX
50
DELISTED
Ignyta, Inc.
RXDX
| $518K | 0.29% |
+50,000
| New | +$518K |
|